Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
—
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is led by CEO Li Li, employs 2,150 people, headquartered in Shenzhen, CN, publicly traded since 2010.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) stock trades at $9.06 with a market capitalization of $14.66B. The stock is valued at a price-to-earnings (P/E) ratio of 71.36, price-to-book of 1.23, price-to-sales of 2.80. Over the past 52 weeks the stock has ranged between $8.50 and $12.68, and currently trades 28.5% below its 52-week high. It pays a dividend yielding 1.45%.
On profitability, Shenzhen Hepalink Pharmaceutical Group Co., Ltd. generates a return on equity (ROE) of 1.62%, an operating margin of 11.98%, a net profit margin of 3.87%.
Official website: www.hepalink.com
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) — frequently asked questions
What is Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) stock price today?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) is currently trading at $9.06, down 2.89% today.
What is 002399.SZ P/E ratio?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'s P/E ratio is 71.36. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is 002399.SZ return on equity (ROE)?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'s return on equity (ROE) is 1.62%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'s market cap?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. has a market capitalization of $14.66B.
Does 002399.SZ pay a dividend?
Yes. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. currently yields 1.45%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 002399.SZ carry?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. has a debt-to-equity ratio of 0.24. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 002399.SZ's profit margin?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. reports a net profit margin of 3.87% — the share of revenue left after every cost, including tax and interest.
What sector is 002399.SZ in?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 002399.SZ listed on?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. trades on SHZ under the ticker 002399.SZ.
What is 002399.SZ's 52-week range?
Over the last year Shenzhen Hepalink Pharmaceutical Group Co., Ltd. has traded between $8.50 and $12.68.
Related — Stocks
Popular Stocks
Screens 002399.SZ currently matches
On the figures above, Shenzhen Hepalink Pharmaceutical Group Co., Ltd. passes the filters for 11 of our ready-made screens, among them Dividend Stocks, Low Debt Stocks, Large Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.